Lisa Winterroth is a Rheumatology/Immunology physician. OpenAlex indexes 6 publications with 244 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9725 3rd Ave NE
Suite 500
Seattle, WA 981152060
Telephone
206-527-2577Provider last certified this registry record 22 Jun 2020.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202524 payments
- GlaxoSmithKline, LLC.Program year202510 payments
- Novartis Pharmaceuticals CorporationProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
99.3%Anti-IgE92.2%Omalizumab99%Xolair1%Part D + Part B<11 patientsCorticosteroid2.5%Fluticasone Propionate40%Qvar Redihaler16%Symbicort15%Dulera15%Arnuity Ellipta14%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
0.3%Corticosteroid0.3%Prednisone100%Part D<11 patientsDermatology
0.3%Interleukin-4 Receptor alpha Antagonist0.3%Dupixent Syringe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
Allergy Asthma and Clinical Immunology
2016 - Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
Allergy Asthma and Clinical Immunology
2014 - Epigenetically Mediated Pathogenic Effects of Phenanthrene on Regulatory T Cells
Journal of Toxicology
2013
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”